A phase I study of ADXS-504, a cancer type specific immunotherapy, for patients with biochemically recurrent prostate cancer. Background: The therapeutic benefit of pelvic lymph node dissection (PLND) ...

The role of pelvic lymph node dissection (PLND) in patients with localized prostate cancer remains controversial. Although guidelines are increasingly recommending extended PLND alongside radical ...

Analysis of the results of intravesical perfusion therapy combined with immediate or non-immediate hematoporphyrin intravesical perfusion photodynamic therapy (PDT) after TURBT for NMIBC. This is an ...

According to a new analysis, PLND does not impact recurrence-free survival but may reduce metastatic spread in intermediate- and high-risk prostate cancer. The benefit of PLND is most evident in ...

Pelvic lymph node dissection is the only reliable method of staging for clinically localized prostate cancer. Despite the obvious prognostic advantages conferred by accurate staging, pelvic lymph node ...

Preoperative (left; top and bottom) and postoperative PSMA-PET/CT images (right; top and bottom) demonstrate the successful removal of two positive pelvic lymph nodes in the radioguided surgical ...

Right Pelvic Lymphocele Investigators have explored various strategies to prevent lymphoceles from forming. Most prostatectomies are now being done with concomitant lymphadenectomy. A few factors are ...

Credit: Getty Images Nevertheless, thorough extended pelvic lymph node dissection cannot be omitted, investigators cautioned. Prostate-specific membrane antigen (PSMA)-guided radical prostatectomy (RP ...

Bladder cancer is one of the most common malignant tumors in urinary system, and the treatment faces huge challenges. Radical cystectomy (RC) is the primary treatment for invasive cases, yet the ...

Clinical node involvement on preoperative PSMA-PET predicts radiographic recurrence for pN1 prostate cancer patients following RP/PLND.